Vascular closure device

Closure Devices Lead Sternal Closure Systems Market: Innovations in Surgical Techniques Boost Adoption - ResearchAndMarkets.com

Retrieved on: 
Friday, November 10, 2023
Surgery, Health, Prevalence, Circulatory system, Patient, Cardiovascular disease, Heart failure, Coronary artery disease, Compound annual growth rate, Sternum, Vascular closure device, Ageing, Trauma, Growth, Video-assisted thoracoscopic surgery, Video game, Dentistry, Health insurance

These systems play a vital role in the closure and stabilization of the sternum following open-heart surgery or sternotomy.

Key Points: 
  • These systems play a vital role in the closure and stabilization of the sternum following open-heart surgery or sternotomy.
  • As these diseases become more common, there is a rising demand for sternal closure systems.
  • Advancements in Surgical Techniques: Innovations in surgical techniques, including minimally invasive cardiac surgeries, have led to a growing need for specialized sternal closure systems that offer stability, reduced trauma, and enhanced patient outcomes.
  • Closure Devices Dominate the Market: Closure devices, including rigid plate systems, wire cerclage systems, and interlocking systems, generated the highest revenue in the sternal closure systems market in 2022.

Global Vascular Closure Devices Market Projected to Reach $1.4 Billion by 2030, Driven by Cardiovascular Health Focus - ResearchAndMarkets.com

Retrieved on: 
Monday, October 9, 2023
Medical Devices, Health, Elixir, Online, Food, Climate change, Developed country, KSR International Co. v. Teleflex Inc., Machine learning, Cardinal Health, Vascular closure device, AI, GDP, Report, Growth, Policy, Access, Pet industry, Video game, Tourism, Renewable energy, Cordis, Euro

The "Vascular Closure Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vascular Closure Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Vascular Closure Devices, estimated at US$824.6 million in 2022, is poised for substantial growth, projected to reach a revised size of US$1.4 billion by 2030, with a notable CAGR of 7.3% over the analysis period from 2022 to 2030.
  • Meanwhile, the growth in the Active Approximators segment is estimated at a commendable 6.5% CAGR for the next 8-year period.
  • The U.S. Market is Estimated at $340.6 Million, While China Shows Strong Growth
    In the United States, the Vascular Closure Devices market is estimated at US$340.6 million in 2022.

Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.

Retrieved on: 
Tuesday, October 10, 2023
Pressure, Diagnosis, Hospital, Physician, NYSE, TSX, Acquisition, FFR, Model Business Corporation Act, Piper, Fractional flow reserve, EBITDA, PCI, HVS Global Hospitality Services, TAVR, DLA, DPR, Workflow, Credit agreements in South Africa, DLA Piper, CAD, Growth, Goldman Sachs, Vascular closure device, GAAP, Patient, Coronary artery disease, Pharmaceutical industry, Medical imaging, Fine chemical, Bank, Haemonetics

BOSTON, Oct. 10, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, and OpSens, Inc. (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that they have entered into a definitive agreement under which Haemonetics will acquire all outstanding shares of OpSens for CAD $2.90 per share in an all-cash transaction representing a fully diluted equity value of approximately USD $253 million at current exchange rate.

Key Points: 
  • OpSens also manufactures a range of fiber optic sensor solutions used in medical devices and other critical industrial applications.
  • Stewart Strong, President, Global Hospital at Haemonetics, said, "With the acquisition of OpSens, we expand our leadership in interventional cardiology and strengthen our foundation for additional growth and diversification.
  • Following this acquisition, Haemonetics' net debt to EBITDA ratio, per the terms set forth in the Company's existing Credit Agreement, is expected to be approximately 2.1x.
  • Haemonetics posted supplemental slides with additional information about this transaction to Haemonetics' investor relations website.

Sternal Closure Systems Global Market Report 2022: Technological Advancements in Sternotomy Techniques Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, December 9, 2022
Surgery, Health, Medical Devices, Stainless steel, Median sternotomy, Plate, Death, Vascular closure device, Surgeon, Growth, PEEK, OR, Wire, USD, Mining, Titanium

Market growth is driven by factors such as the significant adoption of sternal closure products and the rising number of cardiothoracic surgeries.

Key Points: 
  • Market growth is driven by factors such as the significant adoption of sternal closure products and the rising number of cardiothoracic surgeries.
  • The closure device segment accounted for the highest growth rate in the sternal closure systems market, by product, during the forecast period
    Based on product, the sternal closure systems market is divided into two main categories - closure devices (wires, plates & screws, cables & clips) and bone cement.
  • In 2021, the closure devices segment accounted for the largest share of the sternal closure systems market.
  • The median sternotomy segment accounted for the largest share of the sternal closure systems market in 2021.

Laparoscopic Instruments Market: Laparoscopic laser thermal systems to create growth prospects for Laparoscopic Instruments Market

Retrieved on: 
Tuesday, November 1, 2022
Marketing, KG, Awareness, Growth, Vascular closure device, Sample, Pancreatic cancer, Population, Karl Storz SE, Olympus Corporation, Gallbladder, Method, Pain, Laparotomy, Research, Obesity, Industry, Bleeding, Risk, Hospital, Medicine, US missile defense system in Asia-Pacific Region, Endometriosis, Colorectal surgery, Energy, Government, Prostate cancer, CAGR, Endoscopy, Disease, USD, Colon, Review, Product, History, Patient, Kidney, Bariatric surgery, General surgery, Stryker Corporation, Percussion section, Uterine fibroid, Medical imaging, Health insurance, Medical device, Healthcare, Laparoscopy, Laparoscopy, Application

Secondary research is used to identify key companies in the Laparoscopic Instruments market, while primary and secondary research is used to determine their market revenues.

Key Points: 
  • Secondary research is used to identify key companies in the Laparoscopic Instruments market, while primary and secondary research is used to determine their market revenues.
  • This has resulted in an increase in demand for surgery, being the driving force for the laparoscopic instruments market growth.
  • Laparoscopic Instruments Regional Market Insights:
    North America held the largest share in Laparoscopic Instruments Market for the year 2021 accounting for 37.6 percent of the total sales.
  • By Product, the Laparoscopic Instruments Market is segmented into Laparoscopes, Energy Systems, Trocars, Closure Devices, Suction/ Irrigation Device, Insufflation Device, Robot-Assisted Systems and Hand Access Instruments
    By Application, the Laparoscopic Instruments Market is segmented into Colorectal Surgery, Bariatric Surgery, Urological Surgery, Gynaecological Surgery, General Surgery and Other Surgeries
    By End-Users, the Laparoscopic Instruments Market is segmented into Hospital, Clinic and Ambulatory
    Laparoscopic Instruments Market Key Players:

Global Patent Foramen Ovale Closure Devices Market Report to 2027 - Insights, Competitive Landscape and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, August 22, 2022
Medical Devices, Health, Partnership, PFO, COVID-19, Association, Atrial septal defect, Acquisition, Vascular closure device, Semiconductor

To capture and analyze suitable indicators, our experts are closely watching the Patent Foramen Ovale (PFO) Closure Devices' market.

Key Points: 
  • To capture and analyze suitable indicators, our experts are closely watching the Patent Foramen Ovale (PFO) Closure Devices' market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years in Patent Foramen Ovale (PFO) Closure Devices' market.
  • Key companies dominating the Global Patent Foramen Ovale (PFO) Closure Devices' Market.
  • Patent Foramen Ovale (PFO) Closure Devices' related organization, association, forum, and other alliances
    Various End-users who want to know more about the Patent Foramen Ovale (PFO) Closure Devices' Market and latest technological developments in the Patent Foramen Ovale (PFO) Closure Devices' market.

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

Retrieved on: 
Wednesday, June 22, 2022
Cardiology, Security (finance), Length of stay, Franzone, Frequency, Consultant, University, Health, LMA, Associate, GLOBE, Solution, Annual report, Disease, Radiology, Surgeon, Weck, Hemostasis, Haynes, TAVR, Head, University at Buffalo Law School, Meta-analysis, Systematic review, Vascular closure device, Patient, MANTA, BMC, U.S. Securities and Exchange Commission, NYSE, Risk, TAVI, Trial of the century, Mortality, Teleflex, Safety, TFX, Urology, Prostatic urethral lift, U/S, Aortic valve, Anesthesia, Emergency medicine, Medical imaging, MD, QuikClot, Medicine, Pilling

The study will enroll patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.

Key Points: 
  • The study will enroll patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.
  • The resourcing of the MANTA Ultra Study by Teleflex reflects our commitment to providing interventional cardiologists and surgeons with category-defining tools that enable difficult procedures and minimize complications in this case, the complications attributable to large bore access that are inherent to TAVI procedures, said Teleflex Medical Director, Chris Buller, MD.
  • Were excited to embark on the Teleflex MANTA Ultra study, said Dr. Wood.
  • With visualization of the access site during MANTA Device deployment, the study intends to demonstrate that ultrasound allows for precise deployment and positive positioning of the MANTA Device anchor within the vessel.

Global Hemostasis Diagnostic Devices and Equipment Market Report 2022: Analyzers, Coagulation Instrument, Hemostasis Instruments, Reagents and Kits - Analysis & Forecasts 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com

Retrieved on: 
Friday, May 20, 2022
Biotechnology, Health, Medical Devices, Hemostasis, Coagulation, Pfizer, Disease, Blood, Company, Incidence, Patient, American Heart Association, VCD, Code, CVD, Asia-Pacific, PDP, Title 21 of the Code of Federal Regulations, CSL, Johnson & Johnson, PMA, Bandage, Bleeding, Baxter International, Man, Hospital, Technology, Degenerative disease, Vascular closure device, Skin, Wound healing, Becton, Dickinson and Company headquarters, Collagen, Abbott Laboratories, Laboratory, Classification, Cardiovascular disease, Vasoconstriction, C. R. Bard, Medical device, Medical imaging

The hemostasis diagnostic devices and equipment market consists of sales of hemostasis diagnostic devices.

Key Points: 
  • The hemostasis diagnostic devices and equipment market consists of sales of hemostasis diagnostic devices.
  • The main products of hemostasis diagnostic devices and equipment are analyzers, coagulation instruments, other hemostasis instruments, and reagents and kits.
  • Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.2.
  • Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

Retrieved on: 
Wednesday, May 18, 2022
Hemostasis, Population, General manager, U.S. Securities and Exchange Commission, Percutaneous, LMA, MD, MANTA, SAFE, Weck, Patient, TFX, Solution, Health, Emergency medicine, Â, Anesthesia, TEVAR, Clinical trial, Urology, Prostatic urethral lift, IDE, Hospital, Vascular closure device, TAVR, Health Canada, Security (finance), Device, Radiology, NYSE, Annual report, GLOBE, Medical device, Medical imaging, Teleflex, Pilling, QuikClot

WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA Vascular Closure Device the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.1 This approval marks an important milestone in the regulatory plan to expand the availability of the MANTA Device globally and provides access to another uniquely designed device from Teleflex to Canadian clinicians.

Key Points: 
  • WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA Vascular Closure Device the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.1 This approval marks an important milestone in the regulatory plan to expand the availability of the MANTA Device globally and provides access to another uniquely designed device from Teleflex to Canadian clinicians.
  • Our team has been working diligently to obtain this approval and were confident that Health Canada would recognize the benefits of the MANTA Device, said Scott Holstine, President and General Manager of the Teleflex Interventional Business Unit.
  • Percutaneous vascular closure obtained with the MANTA Device without the use of unplanned endovascular or surgical intervention.
  • A single MANTA Vascular Closure Device was deployed in 99.6% of subjects in IDE trial.

Overview of Global Patent Foramen Ovale (PFO) Closure Devices 2021 - 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 1, 2021
Health, General Health, Patent, Review, Mergers and acquisitions, Vascular closure device, Diagnosis, Atrial septal defect, PFO, Epidemiology, Competitive landscape, Research, Retail, Cochineal, Pharmaceutical industry, Medical device, Video game, Pet

This 'Patent Foramen Ovale (PFO) Closure Devices- Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Patent Foramen Ovale Closure Devices and the historical and forecasted Patent Foramen Ovale Closure Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

Key Points: 
  • This 'Patent Foramen Ovale (PFO) Closure Devices- Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Patent Foramen Ovale Closure Devices and the historical and forecasted Patent Foramen Ovale Closure Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • The Patent Foramen Ovale (PFO) Closure Devices market report provides an overview of Patent Foramen Ovale Closure Devices, its cause, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
  • Additionally, this report covers the overview, various treatment practices, and patent foramen ovale closure devices forecasted epidemiology from 2018 to 2026, segmented by the seven major markets.
  • The report is a comprehensive account of marketed devices present in the Patent Foramen Ovale (PFO) Closure Devices market.